Abstracts
Showing 852 abstracts.
Citation
Brookie M. Best, Alice Stek, Edmund Capparelli, Jiajia Wang, David Shapiro, Courtney Fletcher, Elizabeth Smith, Nahida Chakhtoura, Mark Mirochnick for the IMPAACT P1026 Protocol Team. Pregnancy-associated decrease in tenofovir exposure counteracted by concomitant lopinavir/ritonavir. Presented at: IAS 2015.Conference
IAS 2015
Study
P1026S
Citation
Stein Schalkwijk, Rob ter Heine, Angela Colbers, Alwin Huitema, Palolo Denti, Kelly Dooley, Edmund Capparelli, Brookie Best, Tim Cressey, Rick Greupink, Frans Russel, Mark Mirochnick, David Burger. Pregnancy: a barrier to dose reduction of efavirenz?. Presented at: CROI 2016.Conference
CROI 2016
Study
P1026S
Citation
George M. Johnson, M.D., YouGan Wang, Andrew A. Wiznia, M.D., Paul Krogstad, M.D., Sophia S. Lee, M.S., Francesca Aweeka, Pharm.D., Sandra Hayashi, Pharm.D., Sharon Appelbaum Nachman, M.D. Preliminary Evaluation Of Pharmacodynamics In Stable Antiretroviral Experienced HIV-Infected Children Following Initiation Of HAART.Citation
Tim Roy Cressey, B.Sc., Ph.D., Nirun Vanprapar, M.D., M.Sc., Edmund Capparelli, Pharm.D., Wasana Prasitsuebsai, M.D., Linda Aurpibul, M.D., Petronella Muresan, M.S., Achara Eksaengsri, B.Pharm., Elizabeth (Betsy) Smith, M.D., Kenneth McIntosh, M.D., Ram Yogev, M.D., Kulkanya Chokephaibulkit, M.D. Preliminary Pharmacokinetics and Safety of a Novel Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC) and Nevirapine (NVP) versus the Liquid Formulations in HIV-Infected Thai Children. Presented at: 10th Int'l Workshop on Clinical Pharmacology of HIV Therapy.Conference
10th Int'l Workshop on Clinical Pharmacology of HIV Therapy
Study
P1069
Citation
Sandra K. Burchett, M.D., M.S., Andrea Kovacs, M.D., Margaret Khoury, M.D., Florence H. Yong, M.S., Vincent J. Carey, Ph.D., Margo Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Bonnie Zimmer, B.S., Elizabeth Hawkins. Preliminary Toxicity and Tolerability Of 4-Drug Antiretroviral (ARV) Therapy With NRTIs, Nevirapine (NVP) and Ritonavir (RTN) In ARV-Experienced Children With Advanced HIV DIsease.Citation
KK Venkatesh, M Farhad, T Fenton, D Moodley, S Naik, C Nakabiito, L Fairlie, B Makanani, F Saidi, T Chipato, J McIntyre, MG Fowler, BH Chi, JSA Stringer for the PROMISE 1077BF team. Preterm birth among women with ultrasound-based gestational dating in PROMISE 1077BF. Presented at: CROI 2019; 2019 Mar 05.Conference
CROI 2019
Study
1077BF
Citation
Prevalence and characterization of HIV-associated nephropathy and other renal disorders in a cohort of perinatally HIV-1 infected children.Citation
Ceejay L. Boyce, Marley D. Bishop, Sheila M. Styrchak, Kevin Knowles, Cindy Vavro, Rohan Hazra, Ellen Townley, Robert Nixon, Robert A. Smith, Geoffrey S. Gottlieb, Theodore D. Ruel, Andrew A. Wiznia, Lisa M. Frenkel, IMPAACT P1093 Team. Prevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093). Presented at: IAS 2023.Conference
IAS 2023
Study
P1093, P1093
Citation
Ceejay Boyce. Prevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093). Presented at: IAS 2023; 2023 Jul 26.Conference
IAS 2023